Skip to main
DOC
DOC logo

DOC Stock Forecast & Price Target

DOC Analyst Ratings

Based on 11 analyst ratings
Buy
Strong Buy 9%
Buy 55%
Hold 36%
Sell 0%
Strong Sell 0%

Bulls say

Healthpeak Properties maintains a robust outlook, driven by its diversified healthcare portfolio, which comprises approximately 700 properties that include medical office and life science assets, alongside senior housing and skilled nursing facilities. The company is actively enhancing its medical office building (MOB) portfolio through new development projects valued at $148 million, demonstrating strong pre-leasing rates of around 80% and projected stabilized yields in the mid-7% range. This strategic expansion, along with the positive market dynamics surrounding healthcare real estate, underscores a favorable long-term growth trajectory for Healthpeak Properties.

Bears say

Healthpeak Properties's stock outlook is negatively impacted by increased credit risk associated with lab tenants, leading to a revision of the 2026 estimated price-to-adjusted funds from operations (P/AFFOPS) multiple from 13.0x to 12.0x. Additionally, weak leasing activity reported in Q2 has prompted a downgrade in the growth forecast for funds from operations and adjusted funds from operations (FFOPS/AFFOPS) to a compound annual growth rate (CAGR) of +1%/-1% for 2026-2027, down from +2%/+1% previously. The potential headwinds to lab occupancy anticipated in the second half of 2025, driven by slow capital raising efforts, further exacerbates the challenges facing Healthpeak’s financial performance.

DOC has been analyzed by 11 analysts, with a consensus rating of Buy. 9% of analysts recommend a Strong Buy, 55% recommend Buy, 36% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Healthpeak Properties Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Healthpeak Properties Inc (DOC) Forecast

Analysts have given DOC a Buy based on their latest research and market trends.

According to 11 analysts, DOC has a Buy consensus rating as of Nov 4, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $20.82, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $20.82, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Healthpeak Properties Inc (DOC)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.